NGM Biopharmaceuticals (NGM) PT Raised to $33 at Stifel
Get Alerts NGM Hot Sheet
Price: $1.58 -2.47%
Rating Summary:
3 Buy, 7 Hold, 0 Sell
Rating Trend: Down
Today's Overall Ratings:
Up: 13 | Down: 10 | New: 11
Rating Summary:
3 Buy, 7 Hold, 0 Sell
Rating Trend: Down
Today's Overall Ratings:
Up: 13 | Down: 10 | New: 11
Join SI Premium – FREE
Stifel analyst Derek Archila raised the price target on NGM Biopharmaceuticals (NASDAQ: NGM) to $33.00 (from $26.00) while maintaining a Buy rating.
You May Also Be Interested In
- Hyundai Mobis Co Ltd. (012330:KS) PT Raised to KRW340,000 at HSBC
- 29Metals Ltd (29M:AU) PT Lowered to AUD0.50 at RBC Capital
- Estée Lauder (EL) climbs as BofA upgrades to Buy on profit recovery expectations
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!